Minomic Overview

  • Founded
  • 2007
  • Status
  • Private
  • Employees
  • 18
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6.92M
Latest Deal Amount
  • Investors
  • 2

Minomic General Information


Developer of an in vitro diagnostic test designed for the early detection of prostate cancer. The company's diagnostic test uses monoclonal antibody together with other biomarkers to estimate the risk of a patient having aggressive prostate cancer, enabling urologists to recommend a patient to have a biopsy or move on to some form of active surveillance monitoring.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Primary Office
  • Suite 2, Ground Floor
  • 75 Talavera Road
  • Macquarie Park, New South Wales 2113
  • Australia
+61 (02) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Minomic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 29-Nov-2016 $6.92M 000.00 Completed Generating Revenue
2. Grant 11-Jul-2013 00.000 Completed Generating Revenue
1. Early Stage VC 08-Mar-2012 $28.9M $5.35M Completed Generating Revenue
To view Minomic’s complete valuation and funding history, request access »

Minomic Executive Team (3)

Name Title Board Seat Contact Info
Brad Walsh Ph.D Founder, Chief Executive Officer & Board Member
David Burdis Chief Financial Officer & Board Member
David Basseal Chief Commercialization Officer
To view Minomic’s complete executive team members history, request access »

Minomic Board Members (9)

Name Representing Role Since
Brad Walsh Ph.D Minomic Founder, Chief Executive Officer & Board Member 000 0000
David Burdis Minomic Chief Financial Officer & Board Member 000 0000
Gregory Brown Self Board Member 000 0000
Mark De Ambrosis M. H. Carnegie Board Member 000 0000
Nicola Young M. H. Carnegie Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Minomic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Minomic Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Australian Research Council Government 000 0000 000000 0
M. H. Carnegie Asset Manager Minority 000 0000 000000 0
To view Minomic’s complete investors history, request access »